Conduct of clinical trials is grossly inequitable:
👉Only 10% of trials included children.
👉Only 9% were conducted in low-income and middle-income countries (LMICs), 1% in low-income countries
thelancet.com/journals/lan...

New guidance from @thelancet.bsky.social
is charting a new direction for clinical trials.
thelancet.com/series/clini...

"Rather than being satisfied with the current research, we should ask ourselves which children in the world still do not benefit from these advancements."
👉Failure to benefit those without financial riches
👉Mismatch between research priorities and disease burden

But oxygen for all needs action - so we make 52 recommendations for governments, the oxygen industry, global health actors, advocacy groups, academics, and professional bodies to work towards by 2030...

Read more and find out what you can do 🫵
www.thelancet.com/commissions/...

Solution 5 - harness data for decision making with standardised oxygen coverage indicators, ATMOS policy scorecard, fostering a learning health system to continually generate and translate new learning into practice...
#data #impact #monitoring

Solution 4 - foster fair markets and regulation with transparent tendering and pricing, representation from LMICs, regulation that allows multiple oxygen production sources and makes devices fit for purpose...

Solution 3 - coordinate oxygen system management with a national oxygen plan, stakeholder involvement across vertical programs, funding to match need and gaps...

Solution 2 - build resilient oxygen supply systems with context-appropriate solutions that build on what exists, biomedical support and essential infrastructure (especially power), planning for total cost of ownership...